By Bahar Gholipour, Staff Writer
Published: 07/24/2014 12:02 PM EDT on LiveScience
A microscopic organism that lives in cat poop could one day be used as a cancer treatment, researchers say.
Toxoplasma gondii is a single-celled parasite that lives in cats' intestines, but can infect other animals and people as well. Although infections with the Toxoplasma parasite are common among people, very few people show symptoms because their immune system attacks and keeps the parasite from causing illness.
Now, researchers are aiming to harness the immune response triggered by the parasite and direct it to attacking tumors. Although the Toxoplasma parasite is hardly the only microbe studied in the hot field of cancer immunotherapy, it may have some unique abilities, the researchers said.
"We know [that] biologically, this parasite has figured out how to stimulate the exact immune responses you want to fight cancer," said David J. Bzik, a professor of microbiology and immunology at Geisel School of Medicine at Dartmouth College in New Hampshire. [The 10 Most Diabolical and Disgusting Parasites]
Using a genetically modified Toxoplasma parasite, Bzik and his colleagues treated mice that had the skin cancer melanoma and mice that had ovarian cancer. In recent studies, they showed the treatment shrank the tumor and increased the mice's chances of survival.
However, much work is needed before a Toxoplasma-based cancer treatment could exit the lab and enter the clinic, the researchers said.
The Toxoplasma parasite is ubiquitous — it infects most species of warm-blooded animals, and can be found almost anywhere on the planet. "The parasite has learned not to kill the host, as well as not to let the host kill itself — for example, by having too much of an inflammatory response," Bzik said. "In order to accomplish this feat, it has to be able to manipulate the immune responses."
When the parasite invades an animal's body, the host's immune response kills any rapidly replicating parasite cells and protects the host from dying. (Later, when the acute infection is over, the parasite turns into a latent form that the host then carries in tissues, muscles and brain for life.)
Specifically, animals' immune systems respond to Toxoplasma infections by releasing cells called CD8+ T cells — a type of cells that destroy virally infected cells and tumor cells. [11 Surprising Facts About the Immune System]
"It turns out that CD8+ T cells are really important in cancer," Bzik told Live Science. "They are the single most important cell type that can eradicate tumor cells, but their generation is shut down by the tumor."
To jump-start this anti-tumor immune response in mice with cancer, the researchers used a safer form of the Toxoplasma parasite. To do so, they manipulated the parasite's genome so that it was unable to reproduce in animals or people, and therefore, couldn't cause disease.
They made a vaccine from this organism and injected it into large tumors in mice. The parasite then got into the cells that prime the CD8+ T cells and allow them to go to work, attacking the tumor cells, Bzik said.
So far, the researchers have treated melanoma tumors six times — even though the tumors were highly developed, they shrank to a nondetectable size after 12 days and multiple treatments. About 90 percent of the mice survived, Bzik said.
"In an aggressive ovarian cancer, we found similar positive results, but when we treat a really aggressive ovarian cancer — [that is], the most aggressive ovarian cancer model that's out there for mice — we get extended survival, but all the mice eventually succumb to tumors," Bzik said. Still, the researchers could keep the mice alive for a very long time by treating them every two weeks, he said.
Bzik and his colleague said much more research is needed to understand the exact mechanisms behind the immune response that the parasite triggers. Also, before the treatment can be tested in people, researchers will need to do extensive testing to make sure it's safe, they said.
Email Bahar Gholipour or follow her @alterwired. Follow Live Science @livescience, Facebook & Google+. Originally published on Live Science.
Copyright 2014 LiveScience, a TechMediaNetwork company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. ]]>
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.